Re-emergence of Positive Symptoms of Schizophrenia during the Course of Treatment with Risperidone

نویسندگان

  • B. Sivaprakash
  • R. Chandrasekaran
  • Bojir Perme
چکیده

Sir, We would like to respond to the article titled "Re-emergence of positive symptoms of schizophrenia during the course of treatment with risperidone" (Bajaj et al.), that was published in the Indian Journal of Psychiatry, Vol.41/No.2/April, 1999. It was quite interesting to note that these authors had observed a re-emergence of positive symptoms in 7 patients, out of 30 patients of schizophrenia treated with risperidone. We would like to present a brief report of a similar phenomenon observed in one schizophrenic patient undergoing treatment in the Dept. of Psychiatry, JIPMER Hospital, Pondicherry. Mr.X, a 28-yr. old unmarried male was hospitalized in August,1999 with an ICD-10 diagnosis of residual schizophrenia. His illness had, by then, run a chronic unremitting course for three years, with a definite progression from an initial brief phase characterised by overt positive symptoms to the second and chronic stage, comprising all the typical negative symptoms such as avolition, apathy, social withdrawal, anhedonia, blunted affect and a gross reduction in speech output. A detailed cross-sectional evaluation soon after admission did not reveal any disorder of form of thought, delusions, thought-alienation phenomena or perceptual disturbances. Patient's baseline BPRS score was 24. Baseline PANSS profile was as follows : Positive syndrome score=11, negative syndrome score=46, general psychopathology score=39. Risperidone was initiated at a dose of 2 mg/day and gradually incraesed to a total of 8 mg/day in 2 divided doses. After 2 weeks of treatment with 8 mg of risperidone, interesting changes were observed in the patient's clinical profile and his scores on BPRS and PANSS. Total BPRS score had increased to 26, while the PANSS scores were as follows : Positive syndrome score=27, negative syndrome score=27, general psychopathology score=39. These rating scale scores correlated with clinically observed worsening of positive symptoms, especially conceptual disorganization and grandiosity and improvement in negative symptoms.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

Background: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia.Methods: In a double-blinded, placebo-controlled, randomized trial (IRCT registration # 201112125280N7), in ...

متن کامل

The effect of Ascorbic Acid as supplementary treatment with risperidone in controlling the symptoms of schizophrenia: A double-blind, placebo-controlled clinical trial

Background and Objective: Considering the hypothesis of the effects of the use of antioxidants such as ascorbic acid on the improvement of oxidative stress induced by schizophrenia, the present study was designed to investigate the effect of ascorbic acid as an adjunctive therapy with risperidone in controlling the symptoms of schizophrenia. Materials and Methods: This randomized clinical tria...

متن کامل

The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial

Introduction: A number of research studies have shown that the new generation of neuroleptic medications can more effectively contribute to treating negative symptoms of schizophrenia compared with the first generation by influence cognitive functioning. The present study examined the therapeutic effectiveness of manufactured Risperidone and Haloperidol in Iran on treating the negative symptoms...

متن کامل

مقایسه تاثیر ریسپریدون و هالوپریدول بر نشانه های شناختی اسکیزوفرنیا

Background and purpose: Several studies have demonstrated, that atypical antipsychotics attenuate cognitive symptoms of schizophrenia more than first generation of antipsychotics. Because there was no comprehensive and reliable study on evaluating these effects in Iranian population, the research group decided to compare the effects of haloperidol and risperidone, both Iranian drug laboratori...

متن کامل

Effects of Atorvastatin on negative sign in chronic schizophrenia: A double blind clinical trial

The aim of this study was to evaluate the effects of Atorvastatin on negative symptoms in patients with chronic schizophrenia. The study was a prospective, double-blind, 6-week trial. Forty patients participated in the study; 19 patients were assigned to the Atorvastatin group as well as 21 patients to the placebo group. For assessing negative signs, we used Scale for the Assessment of Negative...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 41  شماره 

صفحات  -

تاریخ انتشار 1999